Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Klingel, K.
Right arrow Articles by Kandolf, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klingel, K.
Right arrow Articles by Kandolf, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Molecular mechanisms in enterovirus and parvovirus B19 associated myocarditis and inflammatory cardiomyopathy

K. Klingel*, H.-C. Selinka, M. Sauter, C.-T. Bock, G. Szalay and R. Kandolf

Department of Molecular Pathology, University Hospital of Tübingen, Tübingen, Germany

* Correspondence: Karin Klingel, MD, Department of Molecular Pathology, University Hospital of Tübingen, Liebermeisterstr. 8, D-72076 Tübingen, Germany.

Abstract

Enteroviruses are considered as important agents of acute and chronic myocarditis. Molecular studies in murine coxsackievirus B3 (CVB3) myocarditis have confirmed the decisive role of virus replication in initiating and maintaining cytopathic effects in myocytes, thus sustaining chronic inflammation. At the molecular level, interference with myocyte function is mediated by specific cleavage of host cell proteins by viral proteinases. There is also evidence that virus-induced activation of distinct cellular signal transduction pathways promotes enteroviral replication and myocardial dysfunction. More recently, additional viruses such as adenoviruses and, in particular, parvovirus B19 (PVB19) have been associated with inflammatory cardiomyopathy. Molecular pathology of PVB19-associated myocarditis is characterized by infection of intracardiac endothelial cells, followed by intravascular accumulation, adhesion and penetration of inflammatory cells, resulting in endothelial dysfunction with secondary myocyte necrosis, which may clinically present with symptoms similar to that of myocardial infarction during acute infection.

Key Words: Cardiotropic viruses • coxsackievirus B3 • endothelial dysfunction • microcirculation • signalling pathways

References

  1. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med. 1985;312:885–890[Abstract]
  2. Klingel K, Hohenadl C, Canu A, Seemann M, Mall G, Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage and inflammation. Proc Natl Acad Sci USA. 1992. p. 314–318
  3. Klingel K, Rieger P, Mall G, Selinka H-C, Huber M, Kandolf R. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: Identification of target cells and cytopathic effects. Lab Invest. 1998;78:1227–1237[ISI][Medline]
  4. Kandolf R, Klingel K, Zell R, Selinka H-C, Schneider-Brachert W, Bültmann B. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology. 1993;35:140–151[ISI][Medline]
  5. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90:330–339[Abstract/Free Full Text]
  6. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart. 1997;78:539–543[Abstract/Free Full Text]
  7. Griffin LD, Kearney D, Ni J, et al. Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovasc Pathol. 1995;4:3–11
  8. Grumbach IM, Heim A, Pring-Akerblom P, Vonhof S, Hein WJ, Müller G, Figulla HR. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol. 1999;54:83–88[ISI][Medline]
  9. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic leftventricular dysfunction. Circulation. 1999;99:1348–1354[Abstract/Free Full Text]
  10. Schowengerdt KO, Ni J, Denfield SW, et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation. 1997;96:3549–3554[Abstract/Free Full Text]
  11. Enders G, Dotsch J, Bauer J, et al. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis. 1998;26:355–358[ISI][Medline]
  12. Nigro G, Bastianon V, Colloridi V, et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis. 2000;31:65–69[CrossRef][ISI][Medline]
  13. Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A. Fatal myocarditis associated with acute parvovirus 19 and human herpesvirus 6 coinfection. J Clin Microbiol. 2001;39:4585–4587[Abstract/Free Full Text]
  14. Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminant myocarditis with human herpesvirus-6 infection. Intern Med. 2000;39:632–636[ISI][Medline]
  15. Pankuweit S, Hufnagel G, Eckhardt H, Hermann H, Uttecht S, Maisch B. Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin. 1998;93:223–228[Medline]
  16. Schönian U, Crombach M, Maser S, Maisch B. Cytomegalovirus-associated heart muscle disease. Eur Heart J. 1995;16(suppl O):46–49
  17. Wu TC, Pizzorno MC, Hayward GS, et al. In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS. 1992;6:7777–7785
  18. Hebert MM, Yu C, Towbin JA, Rogers BB. Fatal Epstein-Barr virus myocarditis in a child with repetitive myocarditis. Pediatr Pathol Lab Med. 1995;15:805–812[ISI][Medline]
  19. Herkowitz A, Wu TC, Willoughby SB, et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994;24:1025–1032[Abstract]
  20. Ray CG, Icenogle TB, Minnich LL, Copeland JG, Grogan TM. The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis. J Infect Dis. 1989;159:829–836[ISI][Medline]
  21. Ni J, Bowles NE, Kim YH, Demmler G, Kearney D, Bricker JT, Towbin JA. Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation. 1997;95:133–139[Abstract/Free Full Text]
  22. Thanopoulos BD, Rokas S, Frimas CA, Mantagos SP, Beratis NG. Cardiac involvement in postnatal rubella. Acta Paediatr Scand. 1989;78:141–144[ISI][Medline]
  23. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest. 2000;80:1137–1142[ISI][Medline]
  24. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation. 1997;96:22–24[Abstract/Free Full Text]
  25. de Leeuw N, Melchers WJ, Balk AH, de Jonge N, Galama JM. Study on microbial persistence in end-stage idiopathic dilated cardiomyopathy. Clin Infect Dis. 1999;29:522–525[ISI][Medline]
  26. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182–188[Abstract/Free Full Text]
  27. Tam PE, Messner RP. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol. 1999;73:10113–10121[Abstract/Free Full Text]
  28. Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P. Quantitative analysis of viral RNA kinetics in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. J Gen Virol. 2000;81:2755–2762[Abstract/Free Full Text]
  29. Wessely R, Klingel K, Santana LF, et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest. 1998;102:1444–1453[ISI][Medline]
  30. Badorff C, Gil-Hwan L, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nature Med. 1999;5:320–326[CrossRef][ISI][Medline]
  31. Huber M, Selinka H-C, Kandolf R. Tyrosine phosphorylation events during coxsackievirus B3 replication. J Virol. 1997;71:595–600[Abstract]
  32. Huber M, Watson KA, Selinka H-C, et al. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol. 1999;73:3587–3594[Abstract/Free Full Text]
  33. Luo H, Yanagawa B, Zhang J, et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol. 2002;76:3365–3373[Abstract/Free Full Text]
  34. Opavsky MA, Martino T, Rabinovitch M, et al. Enhanced ERK1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest. 2002;109:1561–1569[CrossRef][ISI][Medline]
  35. Huttunen P, Hyypiä T, Vihinen P, Nissinen L, Heino J. Echovirus 1 infection induces both stress- and growth-activated mitogen-activated protein kinase pathways and regulates the transcription of cellular immediate-early genes. Virology. 1998;250:85–93[CrossRef][ISI][Medline]
  36. Fenton M, Sinclair AJ. Divergent requirements for the MAPK/ERK signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. J Virol. 1999;73:8913–8916[Abstract/Free Full Text]
  37. Young NS. Parvoviruses. Fields BN, Knipe DM, Howley PM. Virology. Philadelphia: Lippincott-Raven; 1996. p. 2199–2220
  38. Dingli D, Pfizenmaier DH, Arromdee E, et al. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet. 2000;356:312–314
  39. Finkel TH, Torok TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet. 1994;343:1255–1258[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. Lupescu, C.-T. Bock, P. A. Lang, S. Aberle, H. Kaiser, R. Kandolf, and F. Lang
Phospholipase A2 Activity-Dependent Stimulation of Ca2+ Entry by Human Parvovirus B19 Capsid Protein VP1
J. Virol., November 15, 2006; 80(22): 11370 - 11380.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Klingel, K.
Right arrow Articles by Kandolf, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klingel, K.
Right arrow Articles by Kandolf, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?